Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3034% above fair value
$700.22+0.78 (+0.11%)
Close on Nov 13, 2026Market cap $259.44BP/E 37.0Yield 0.25%
Thermo Fisher Scientific total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Thermo Fisher Scientific's total debt was $41.37B at Sep 26, 2026. For fiscal 2025 it was $39.39B, up 25.9% from the year before. Over ten years it grew 12.2% a year on average. The highest annual figure on record is $39.39B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.39B | +25.9% |
| FY2024 | Dec 31, 2024 | $31.28B | -10.4% |
| FY2023 | Dec 31, 2023 | $34.92B | +1.2% |
| FY2022 | Dec 31, 2022 | $34.49B | -1.1% |
| FY2021 | Dec 31, 2021 | $34.87B | +60.4% |
| FY2020 | Dec 31, 2020 | $21.74B | +22.4% |
| FY2019 | Dec 31, 2019 | $17.75B | -6.5% |
| FY2018 | Dec 31, 2018 | $18.99B | -9.6% |
| FY2017 | Dec 31, 2017 | $21.01B | +26.3% |
| FY2016 | Dec 31, 2016 | $16.63B | +33.3% |
| FY2015 | Dec 31, 2015 | $12.47B | -14.4% |
| FY2014 | Dec 31, 2014 | $14.56B | +38.9% |
| FY2013 | Dec 31, 2013 | $10.49B | +47.2% |
| FY2012 | Dec 31, 2012 | $7.12B | +1.4% |
| FY2011 | Dec 31, 2011 | $7.03B | +228.9% |
| FY2010 | Dec 31, 2010 | $2.14B | -2.0% |
| FY2009 | Dec 31, 2009 | $2.18B | +8.1% |
| FY2008 | Dec 31, 2008 | $2.02B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $41.37B | +15.9% |
| Q2 FY2026 | Jun 27, 2026 | $42.55B | +20.8% |
| Q1 FY2026 | Mar 28, 2026 | $43.16B | +26.2% |
| Q4 FY2025 | Dec 31, 2025 | $39.39B | +25.9% |
| Q3 FY2025 | Sep 27, 2025 | $35.68B | +1.0% |
| Q2 FY2025 | Jun 28, 2025 | $35.23B | -0.5% |
| Q1 FY2025 | Mar 29, 2025 | $34.19B | -4.0% |
| Q4 FY2024 | Dec 31, 2024 | $31.28B | -10.4% |
| Q3 FY2024 | Sep 28, 2024 | $35.31B | +0.1% |
| Q2 FY2024 | Jun 29, 2024 | $35.41B | +4.1% |
| Q1 FY2024 | Mar 30, 2024 | $35.61B | +1.0% |
| Q4 FY2023 | Dec 31, 2023 | $34.92B | +1.2% |
| Q3 FY2023 | Sep 30, 2023 | $35.28B | +21.0% |
| Q2 FY2023 | Jul 1, 2023 | $34.01B | +12.4% |
| Q1 FY2023 | Apr 1, 2023 | $35.26B | +6.0% |
| Q4 FY2022 | Dec 31, 2022 | $34.49B | -1.1% |
| Q3 FY2022 | Oct 1, 2022 | $29.16B | +34.3% |
| Q2 FY2022 | Jul 2, 2022 | $30.26B | +61.2% |
| Q1 FY2022 | Apr 2, 2022 | $33.26B | +78.4% |
| Q4 FY2021 | Dec 31, 2021 | $34.87B | +60.4% |
| Q3 FY2021 | Oct 2, 2021 | $21.71B | +2.9% |
| Q2 FY2021 | Jul 3, 2021 | $18.78B | -11.9% |
| Q1 FY2021 | Apr 3, 2021 | $18.65B | -6.6% |
| Q4 FY2020 | Dec 31, 2020 | $21.74B | +22.4% |
| Q3 FY2020 | Sep 26, 2020 | $21.09B | +23.7% |
| Q2 FY2020 | Jun 27, 2020 | $21.31B | +11.9% |
| Q1 FY2020 | Mar 28, 2020 | $19.97B | +10.0% |
| Q4 FY2019 | Dec 31, 2019 | $17.75B | -6.5% |
| Q3 FY2019 | Sep 28, 2019 | $17.05B | -9.2% |
| Q2 FY2019 | Jun 29, 2019 | $19.04B | -2.0% |
| Q1 FY2019 | Mar 30, 2019 | $18.15B | -13.3% |
| Q4 FY2018 | Dec 31, 2018 | $18.99B | -9.6% |
| Q3 FY2018 | Sep 29, 2018 | $18.77B | -14.6% |
| Q2 FY2018 | Jun 30, 2018 | $19.42B | +15.6% |
| Q1 FY2018 | Mar 31, 2018 | $20.94B | +22.6% |
| Q4 FY2017 | Dec 31, 2017 | $21.01B | +26.3% |
| Q3 FY2017 | Sep 30, 2017 | $21.99B | – |
| Q2 FY2017 | Jul 1, 2017 | $16.80B | – |
| Q1 FY2017 | Apr 1, 2017 | $17.07B | – |
| Q4 FY2016 | Dec 31, 2016 | $16.63B | – |
See a number that looks wrong?